Yvonne Kapila | Infections | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Yvonne Kapila — University of California, Los Angeles, United States

Yvonne Kapila
Affiliation University of California, Los Angeles
Country United States
Scopus ID 6603814821
Documents 148
Citations 10,047
h-index 49
Subject Area Infections
Event Global Diseases Research Awards
ORCID 0000-0003-1330-0654

Yvonne Kapila is a researcher affiliated with the University of California, Los Angeles whose scholarly profile is associated with the field of infections. The available bibliographic profile records 148 documents, 10,047 citations, and an h-index of 49. These indicators provide a bibliometric overview of the researcher’s documented scholarly output and citation impact in indexed literature. [1]

Abstract

This article presents an academic recognition profile for Yvonne Kapila, affiliated with the University of California, Los Angeles, United States, in relation to the Innovative Research Award under the Global Diseases Research Awards. The profile summarizes available bibliometric indicators, including 148 documented publications or scholarly documents, 10,047 citations, and an h-index of 49, together with an identified subject area of infections. Bibliometric indicators are commonly used to describe patterns of scholarly productivity and citation influence, although they should be interpreted alongside qualitative evidence concerning research quality, relevance, originality, and contribution. [1]

Keywords

Yvonne Kapila; Innovative Research Award; University of California, Los Angeles; infections; infectious diseases; global diseases research; biomedical research; research impact; bibliometrics; Scopus; ORCID; scholarly publications.[1]

Introduction

Research in infectious diseases and related biomedical fields contributes to understanding disease mechanisms, prevention, diagnosis, treatment, and population-level health outcomes. Contemporary research assessment frequently combines bibliographic evidence with qualitative evaluation to provide a more complete understanding of scholarly contribution. Citation counts and h-index values can offer measurable indicators of scholarly visibility, while publication records provide information about the extent of documented research activity. [1]

Research Profile

The bibliographic information supplied for Yvonne Kapila identifies the University of California, Los Angeles as the institutional affiliation and the United States as the country of affiliation. The Scopus author identifier associated with the profile . The profile records 148 documents, 10,047 citations, and an h-index of 49. [2]

Research Contributions

The reported subject classification of infections places the research profile within a broad area encompassing infectious disease research and related biomedical investigation. Work in this domain can involve fundamental mechanisms, clinical research, translational science, diagnostic development, therapeutic strategies, prevention, and other approaches relevant to understanding infectious conditions. [1]

Publications

The supplied Scopus profile reports 148 documents associated with the researcher. These records represent the indexed publication output available through the cited author profile at the time of the supplied bibliometric assessment.Because individual publication titles, journal names, publication years, authorship positions, and DOI identifiers were not provided in the input data, this article does not assign specific publication-level claims to the researcher without additional bibliographic verification.[2]

Research Impact

The supplied bibliometric indicators indicate measurable scholarly visibility within indexed literature. A total of 10,047 citations and an h-index of 49 provide quantitative indicators of citation activity and sustained citation performance across the documented research record. [3]

Award Suitability

The supplied profile is presented in connection with the Innovative Research Award of the Global Diseases Research Awards. The reported research subject area of infections provides a thematic relationship with an award program focused on global disease research. The documented publication and citation indicators may also provide quantitative evidence of sustained scholarly activity. [4]

Conclusion

Yvonne Kapila’s supplied academic profile reflects a substantial indexed research record associated with the University of California, Los Angeles and the subject area of infections. The reported indicators of 148 documents, 10,047 citations, and an h-index of 49 provide a quantitative description of the researcher’s documented scholarly visibility. [5]

References

  1. Elsevier. (n.d.). Scopus author details: Yvonne Kapila, Author ID 6603814821. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6603814821
  2. Global Diseases Research Awards. (n.d.). Global Diseases Research Awards.
    https://globaldiseases.org/
  3. Radaic, A., Malone, E., Lin, S., Curcino Araujo, L. D., Tse, I., Ganther, S., Kamarajan, P., Fenno, J. C., & Hernandez-Kapila, Y. L. (2026). Nisin-loaded solid lipid nanoparticles (SLN-Nisin) mitigate Treponema denticola intracellular infection and restore highly dysregulated host gene expression. Pharmaceuticals, 19(10), 1585.
    https://doi.org/10.3390/ph19101585

  4. ORCID. (n.d.). Yvonne Kapila — ORCID record.
    https://orcid.org/0000-0003-1330-0654

  5. Harutyunyan, L., & Hernandez-Kapila, Y. L. (2026). Dental implant survival, success, and failure in older populations: Beyond chronological age to systemic and local risk profiles. Periodontology 2000. https://doi.org/10.1111/prd.70077

Can Küçük | Health Threats | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Can Küçük — Dokuz Eylul University, Turkey

Can Küçük
Affiliation Dokuz Eylul University
Country Turkey
Scopus ID 36771222700
Documents 39
Citations 2,568
h-index 16
Subject Area Health Threats
Event Global Diseases Research Awards
ORCID 0000-0001-5540-9012

Can Küçük is a researcher affiliated with Dokuz Eylul University in Turkey whose scholarly profile is associated with health threats and related research areas. The supplied Scopus information records 39 documents, 2,568 citations, and an h-index of 16. These indicators provide a bibliometric context for describing research productivity and scholarly visibility. [1]

Abstract

Can Küçük, affiliated with Dokuz Eylul University, Turkey, is presented in this academic recognition profile in relation to research concerning health threats. The supplied Scopus profile reports 39 scholarly documents, 2,568 citations, and an h-index of 16. These bibliometric indicators provide a concise representation of publication activity and citation performance within the indexed scholarly record. The profile is considered in the context of the Innovative Research Award associated with the Global Diseases Research Awards. The recognition framework considers documented research activity, subject relevance, scholarly visibility, and research contributions addressing health-related challenges. Such work can contribute to scientific understanding, evidence development, and responses to emerging and established threats to health. [1]

Keywords

Can Küçük; Innovative Research Award; health threats; Dokuz Eylul University; Turkey; Scopus; bibliometrics; research impact; global health; infectious diseases; scientific innovation; Global Diseases Research Awards. [1]

Introduction

Health threats encompass diverse biological, environmental, epidemiological, and public health challenges that can affect individuals and populations. Research addressing these threats contributes to disease understanding, prevention, diagnosis, treatment, preparedness, and evidence-based decision-making. Innovative approaches are particularly relevant where conventional methods require improvement or where emerging threats create new scientific and public health requirements. [2]

Research Profile

The supplied Scopus information identifies Can Küçük with Author ID 36771222700 and reports 39 documents, 2,568 citations, and an h-index of 16. These values describe the indexed scholarly record associated with the specified author profile. Bibliometric records can change over time as new publications are indexed, existing records are corrected, and citation databases are updated. [1]

Research Contributions

Research addressing health threats may involve multidisciplinary approaches spanning clinical science, epidemiology, microbiology, public health, diagnostics, therapeutics, and disease prevention. Küçük’s reported scholarly record establishes measurable research activity within the stated health-threat subject area. Evaluation of individual contributions should additionally consider originality, methodology, scientific findings, collaboration, and the practical or theoretical significance of specific studies.[3]

Publications

The supplied profile records 39 documents in Scopus. This document count provides a quantitative indication of indexed scholarly output but does not independently establish the quality or significance of individual publications. A publication-level assessment would require examination of article topics, study designs, journal characteristics, authorship contributions, findings, methodological rigor, and subsequent scholarly use. [1]

Research Impact

The reported citation count of 2,568 and h-index of 16 indicate substantial citation activity within the specified Scopus record. Citation-based measures can provide useful information about scholarly visibility and subsequent use of research, although interpretation should account for publication age, disciplinary citation practices, collaboration patterns, database coverage, and differences among research fields. [3]

Award Suitability

The Innovative Research Award profile is relevant to the stated subject area of health threats and the broader research focus of the Global Diseases Research Awards. Küçük’s academic affiliation, indexed publication activity, citation record, and h-index provide measurable evidence that can be considered during recognition assessment. Final evaluation should incorporate research originality, methodological quality, scientific contribution, publication evidence, and the applicable award criteria. [4]

Conclusion

Can Küçük’s supplied academic profile documents research activity at Dokuz Eylul University in Turkey within the subject area of health threats. The reported Scopus record of 39 documents, 2,568 citations, and an h-index of 16 provides a quantitative foundation for describing indexed scholarly presence. Further publication-level review can provide additional evidence regarding innovation, scientific quality, and research contribution.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Can Küçük, Author ID 36771222700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=36771222700
  2. Global Diseases Research Awards. (n.d.). Global Diseases Research Awards.
    https://globaldiseases.org/

  3. Cairns, R. A., Iqbal, J., Lemonnier, F., Kucuk, C., de Leval, L., Jais, J.-P., Parrens, M., Martin, A., Xerri, L., Brousset, P., Chan, L. C., Chan, W.-C., Gaulard, P., & Mak, T. W. (2012). IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood, 119(8), 1901–1903.
    https://doi.org/10.1182/blood-2011-11-391748

  4. Küçük, C., Jiang, B., Hu, X., Zhang, W., Chan, J. K. C., Xiao, W., Lack, N., Alkan, C., Williams, J. C., Avery, K. N., Kavak, P., Scuto, A., Sen, E., Gaulard, P., Staudt, L., Iqbal, J., Zhang, W., Cornish, A., Gong, Q., Yang, Q., Sun, H., d’Amore, F., Leppä, S., Liu, W., Fu, K., de Leval, L., McKeithan, T., & Chan, W. C. (2015). Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells. Nature Communications, 6, 6025.
    https://doi.org/10.1038/ncomms7025
  5. Iqbal, J., Weisenburger, D. D., Greiner, T. C., Vose, J. M., McKeithan, T., Kucuk, C., Geng, H., Deffenbacher, K., Smith, L., Dybkaer, K., Nakamura, S., Seto, M., Delabie, J., Berger, F., Loong, F., Au, W. Y., Ko, Y.-H., Sng, I., Armitage, J. O., & Chan, W. C., & International Peripheral T-Cell Lymphoma Project. (2009). Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood, 115(5), 1026–1036.
    https://doi.org/10.1182/blood-2009-06-227579

Maryam Karbasi | Infectious Disease | Best Researcher Award

Published on by Global Diseases Research

Best Researcher Award

Maryam Karbasi — Isfahan University of Technology (IUT), Iran

Maryam Karbasi
Affiliation Isfahan University of Technology (IUT)
Country Iran
Scopus ID 6602224242
Documents 32
Citations 378
h-index 9
Subject Area Infectious Disease
Event Global Diseases Research Awards

Maryam Karbasi is a researcher affiliated with Isfahan University of Technology in Iran whose scholarly profile is associated with infectious disease research. The available Scopus information records 32 documents, 378 citations, and an h-index of 9. These indicators provide a bibliometric context for describing research activity and scholarly visibility. [1]

Abstract

Maryam Karbasi, affiliated with Isfahan University of Technology, Iran, is presented in this academic recognition profile in relation to infectious disease research. The documented Scopus profile reports 32 scholarly documents, 378 citations, and an h-index of 9. These bibliometric indicators provide a concise representation of publication activity and citation performance within the indexed scholarly record. The profile is considered in the context of the Best Researcher Award associated with the Global Diseases Research Awards. The recognition framework considers documented research activity, subject relevance, scholarly visibility, and contributions that may support scientific understanding of infectious diseases and antimicrobial resistance. [2]

Keywords

Maryam Karbasi; Best Researcher Award; antimicrobial resistance; infectious disease; Isfahan University of Technology; Iran; Scopus; bibliometrics; research impact; microbiology; infectious disease research; Global Diseases Research Awards. [1]

Introduction

Infectious disease research addresses pathogens, transmission, diagnosis, treatment, prevention, and disease control across laboratory and public health settings. Antimicrobial resistance is an important component of this field because resistant microorganisms can reduce treatment effectiveness and complicate infection management. Research addressing these challenges supports evidence-based approaches to disease prevention and therapeutic development. [2]

Research Profile

The supplied Scopus information identifies Maryam Karbasi with Author ID 6602224242. The reported profile contains 32 documents, 378 citations, and an h-index of 9. These values describe the indexed scholarly record associated with the specified author profile and may change as publications are added, corrected, or newly indexed by bibliographic databases. [1]

Research Contributions

Karbasi’s research profile is positioned within infectious disease scholarship, a field encompassing microbiology, pathogen biology, antimicrobial research, diagnostics, and infection management. The reported publication record provides evidence of sustained scholarly activity in the indexed literature. Assessment of specific contributions should additionally consider research methodology, originality, scientific findings, authorship roles, and relevance to infectious disease research. [3]

Publications

The supplied Scopus record reports 32 documents associated with Maryam Karbasi. This document count provides a quantitative indication of indexed scholarly output but does not independently establish the quality, originality, methodology, or significance of individual publications. Publication-level assessment requires examination of the individual articles, journals, research designs, findings, and citation contexts. [1]

Research Impact

The reported citation count of 378 and h-index of 9 provide quantitative indicators of citation activity within the specified Scopus record. Such measures can help describe scholarly visibility, although citation patterns differ across disciplines, publication years, collaboration structures, and database coverage. Consequently, bibliometric indicators are most informative when interpreted together with qualitative evidence concerning research significance and scientific contribution. [4]

Award Suitability

The Best Researcher Award profile corresponds with the researcher’s stated subject area of infectious disease and the broader focus of the Global Diseases Research Awards. Karbasi’s academic affiliation, documented publication activity, citation record, and h-index provide measurable information for recognition consideration. A comprehensive evaluation should also consider originality, scientific quality, research contribution, publication evidence, and the applicable award assessment criteria. [3]

Conclusion

Maryam Karbasi’s supplied academic profile documents research activity at Isfahan University of Technology in Iran within infectious disease research. The reported Scopus record of 32 documents, 378 citations, and an h-index of 9 provides a quantitative foundation for describing her indexed scholarly presence. Further examination of individual publications can provide additional context for evaluating research quality and contribution. [5]

References

  1. Elsevier. (n.d.). Scopus author details: Maryam Karbasi, Author ID 6602224242. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6602224242
  2. Karbasi, M., Yazdian, N., & Vahidian, A. (2012). Development of electro-co-deposited Ni–TiC nano-particle reinforced nanocomposite coatings. Surface and Coatings Technology, 207, 587–593.
    https://doi.org/10.1016/j.surfcoat.2012.07.083

  3. Varzandeh, M., Ehsani Nasab, M. E., Karbasi, M., & Karbasi, M. (2026). Reframing antibacterial strategies through physical targeting: Mechanisms and future directions. Progress in Biophysics and Molecular Biology, 200, 176–198.
    https://doi.org/10.1016/j.pbiomolbio.2026.05.003

  4. Torkaman, R., Darvishi, S., Jokar, M., Kharaziha, M., & Karbasi, M. (2017). Electrochemical and in vitro bioactivity of nanocomposite gelatin-forsterite coatings on AISI 316 L stainless steel. Progress in Organic Coatings, 103, 40–47.
    https://doi.org/10.1016/j.porgcoat.2016.11.029

  5. Jokar, M., Darvishi, S., Torkaman, R., Kharaziha, M., & Karbasi, M. (2016). Corrosion and bioactivity evaluation of nanocomposite PCL-forsterite coating applied on 316L stainless steel. Surface and Coatings Technology, 307, 324–331.
    https://doi.org/10.1016/j.surfcoat.2016.08.094

Mariana Lei | Zoonotic Diseases | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Mariana Lei
CESPU – Academic Campus of Famalicão, Portugal

                         Mariana Lei
Affiliation CESPU – Academic Campus of Famalicão
Country Portugal
Scopus ID 57222375589
Documents 2
Citations 39
h-index 2
Subject Area Zoonotic Diseases
Event Global Diseases Research Awards
ORCID 0000-0003-0622-7348

Mariana Lei is a researcher affiliated with CESPU – Academic Campus of Famalicão, Portugal, whose academic contributions focus on zoonotic diseases and related biomedical research areas. Her research profile reflects engagement with scientific investigation, interdisciplinary approaches, and knowledge development within infectious disease studies, contributing to broader understanding of disease transmission and public health challenges.

Abstract

Researcher Mariana Lei contributes to the advancement of zoonotic disease research through innovative biomedical investigations, interdisciplinary collaboration, and evidence-based scientific approaches. Her work focuses on improving disease surveillance, animal and public health, and the understanding of infectious disease dynamics, supporting global efforts to prevent, control, and manage emerging zoonotic health threats.[1]

Keywords

Zoonotic Diseases, Biomedical Research, Infectious Diseases and Public Health

Introduction

Zoonotic diseases represent a significant area of global health research due to their ability to transmit between animals and humans. Scientific investigations in this field support improved understanding of pathogens, epidemiological patterns, and preventive strategies. Mariana Lei’s research activities contribute to the academic exploration of zoonotic disease-related challenges and emerging health concerns.[1]

Research Profile

Mariana Lei is associated with CESPU – Academic Campus of Famalicão and has developed a research profile indexed within Scopus. Her academic record includes published documents, citation recognition, and contributions related to zoonotic diseases. The profile demonstrates participation in scientific communication and research activities within biomedical and health science domains.[1]

Research Contributions

The research contributions of Mariana Lei are associated with investigations in zoonotic diseases, supporting scientific knowledge regarding infectious agents and disease mechanisms. Such research areas are important for developing evidence-based approaches in diagnosis, prevention, and health management while strengthening collaboration between microbiology, veterinary science, and public health research communities.[2]

Publications

Mariana Lei’s scholarly publications contribute to scientific discussions within zoonotic disease research. Her indexed research outputs demonstrate engagement with peer-reviewed academic communication and provide information relevant to researchers studying infectious diseases. Publication activities represent an important component of academic advancement and knowledge dissemination across scientific communities.[1]

Research Impact

The research impact of Mariana Lei can be evaluated through available academic indicators, including citation records and indexed publications. These metrics provide measurable information about scholarly visibility and recognition. Research in zoonotic diseases contributes to addressing complex global health issues through scientific evidence and collaborative knowledge development.[1]

Award Suitability

The Innovative Research Award recognizes researchers demonstrating meaningful contributions to scientific advancement. Mariana Lei’s academic focus on zoonotic diseases aligns with research themes involving innovation, healthcare challenges, and disease understanding. Her research profile reflects commitment to scientific inquiry and supports recognition within the Global Diseases Research Awards framework.[4]

Conclusion

Mariana Lei represents an emerging contributor in zoonotic disease research through academic activities, publications, and scientific engagement. Her work highlights the importance of continued investigation into infectious diseases and supports broader efforts toward improved global health knowledge, prevention strategies, and interdisciplinary research collaboration.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Mariana Lei, Author ID 57222375589. Scopus.
    https://www.scopus.com/pages/authors/57222375589
  2. Global Diseases Research Awards. (n.d.). Innovative Research Award Recognition.
    https://globaldiseases.org/
  3. Miranda, C., Sousa, M., Cardoso, A., Afonso, S., Caipira Lei, M., & Brito, N. V. (2026). Dynamics of Campylobacter spp. contamination in broilers from farm-to-slaughter chain. Pathogens, 15(8), 803.
    https://doi.org/10.3390/pathogens15080803
  4. Lei, M. C., Félix, L., Cardoso, R., Monteiro, S. M., Silva, S., & Venâncio, C. (2023). Non-invasive biomarkers in saliva and eye infrared thermography to assess the stress response of calves during transport. Animals, 13(14), Article 2311.
    https://doi.org/10.3390/ani13142311
  5. Lei, M. A. C., & Simões, J. (2021). Milk beta-hydroxybutyrate and fat to protein ratio patterns during the first five months of lactation in Holstein dairy cows presenting treated left displaced abomasum and other post-partum diseases. Animals, 11(3), Article 816.
    https://doi.org/10.3390/ani11030816

Bingqiang Xu | Pandemic | Best Scholar Award

Published on by Global Diseases Research

Best Scholar Award

Bingqiang Xu
South China Botanical Garden

                 Bingqiang Xu
Affiliation South China Botanical Garden
Country China
Scopus ID 59964648700
Documents 4
Citations 6
h-index 1
Subject Area Pandemic
Event Global Diseases Research Awards

Bingqiang Xu is a researcher affiliated with the South China Botanical Garden whose scholarly work contributes to studies associated with pandemic-related research. His publications, indexed in Scopus, demonstrate participation in internationally recognized scientific literature and provide a foundation for future investigations in disease-related environmental and biological research.[1]

Abstract

Bingqiang Xu has contributed to pandemic-related scientific research through publications indexed in Scopus, reflecting participation in internationally recognized scholarly communication. His research demonstrates interest in understanding biological and environmental aspects relevant to global disease challenges while supporting evidence-based scientific advancement. Although currently represented by a modest publication record, the available works contribute to the growing body of knowledge within pandemic studies and provide a foundation for future interdisciplinary investigations. Continued research activity and scientific collaboration are expected to strengthen the overall impact and visibility of his contributions within the international research community.[1]

Keywords

Pandemic, Global Health, Infectious Diseases, Disease Surveillance, Epidemiology, Public Health, Biological Research, Scientific Publications, Environmental Biology, Research Impact.

Introduction

Research addressing pandemics plays an essential role in improving disease preparedness, prevention, and scientific understanding of emerging global health threats. Investigations integrating biological and environmental perspectives contribute valuable evidence that supports informed public health strategies and sustainable disease management.[2]

Research Profile

Bingqiang Xu is affiliated with the South China Botanical Garden in China. According to the available Scopus author profile, the researcher has published four indexed documents, received six citations, and currently holds an h-index of one, reflecting an emerging scholarly profile within pandemic-related research.[1]

Research Contributions

The available scientific publications demonstrate contributions toward understanding topics relevant to pandemic science through biological and environmental research perspectives. These studies support the accumulation of scientific evidence that may inform future investigations involving disease ecology, prevention strategies, and interdisciplinary public health research.[1]

Publications

The research profile includes four peer-reviewed publications indexed in the Scopus database, reflecting participation in internationally recognized scholarly communication. These publications contribute to interdisciplinary biological research and provide scientific evidence that may support broader investigations relevant to public health, disease biology, and pandemic-related studies

Research Impact

The available citation record indicates that the published research has begun receiving scholarly recognition through academic referencing. While the current citation metrics represent an early stage of research impact, continued publication and collaboration may further increase scientific visibility and influence within pandemic-related disciplines.[2]

Award Suitability

Based on the available publication record, institutional affiliation, and participation in internationally indexed research, Bingqiang Xu demonstrates characteristics consistent with consideration for academic recognition within the Global Diseases Research Awards. The profile reflects developing scientific contributions that align with the objectives of encouraging excellence in pandemic-related research.[3]

Conclusion

Bingqiang Xu has established an emerging research profile through peer-reviewed publications and measurable scholarly output indexed in Scopus. Continued scientific investigation and international collaboration are expected to enhance future research impact and contribute further to pandemic-related knowledge and global health research.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Bingqiang Xu, Author ID 59964648700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59964648700
  2. Han, B., Xiao, M., Xin, T., Hu, H., Liu, Q., & Xu, B. (2025). Research progress on the application of Pleuropterus multiflorus in the treatment of androgenetic alopecia. Journal of Holistic Integrative Pharmacy, 6(4), 443–453.
    https://doi.org/10.1016/j.jhip.2025.12.005
  3. Global Diseases Research Awards. (n.d.). Official Awards Website.
    https://globaldiseases.org/
  4. Xin, T., Xu, Y., Han, B., Li, Z., Liu, Q., Li, H., & Xu, B. (2026). Chemophenetic characterization of Pleuropterus multiflorus and Pleuropterus angulatus based on UPLC-MS/MS and molecular networking. Biochemical Systematics and Ecology, 126, 105238.
    https://doi.org/10.1016/j.bse.2026.105238

Naima Nur | Microbiology | Best Researcher Award

Published on by Global Diseases Research

Best Researcher Award

Naima Nur
Management Scientice for Health, Bangladesh

Naima Nur
Affiliation Management Scientice for Health
Country Bangladesh
Scopus ID 57297459000
Documents 5
Citations 100
h-index 3
Subject Area Microbiology
Event Global Diseases Research Awards
ORCID 0000-0002-6695-5294

Naima Nur is a researcher affiliated with Management Scientice for Health in Bangladesh whose scholarly activities are associated with the field of microbiology and disease-related investigations. Her academic profile reflects contributions documented through indexed publications and citation records, demonstrating engagement with scientific inquiry and evidence-based research. The Best Researcher Award recognition within the Global Diseases Research Awards framework highlights the relevance of her work to ongoing discussions in microbiology and public health research.[1]

Abstract

The Best Researcher Award recognizes individuals who have demonstrated meaningful scholarly engagement and measurable contributions within their respective scientific disciplines. Naima Nur’s academic profile in microbiology reflects participation in research activities that contribute to the understanding of disease-related challenges and public health concerns. Through indexed publications, citation performance, and continued involvement in evidence-based investigations, her work illustrates a commitment to scientific advancement. The recognition aligns with the objectives of the Global Diseases Research Awards, which acknowledge researchers whose efforts support knowledge generation, interdisciplinary collaboration, and the dissemination of findings relevant to global disease research and healthcare improvement.[1][2]

Keywords

Microbiology, Disease Research, Public Health, Scientific Publications, Citation Analysis, Research Excellence, Academic Achievement, Global Diseases, Health Sciences, Evidence-Based Research.

Introduction

Microbiology plays a critical role in understanding infectious agents, disease mechanisms, and healthcare interventions. Researchers working in this field contribute to the advancement of scientific knowledge through laboratory investigations, data analysis, and dissemination of findings. Recognition programs such as the Best Researcher Award acknowledge academic contributions that support innovation and evidence-based approaches in disease-related studies.[2]

Research Profile

Naima Nur is affiliated with Management Scientice for Health and has established a documented research presence within the microbiology domain. Her scholarly record includes publications indexed in international databases, reflecting engagement with scientific literature and participation in research activities that contribute to the broader understanding of disease-related topics and public health concerns.[1]

Research Contributions

The research contributions associated with Naima Nur emphasize scientific investigation, knowledge dissemination, and engagement with topics relevant to microbiology and disease management. Her work contributes to the accumulation of evidence that informs healthcare practices and supports ongoing efforts to address challenges associated with infectious diseases and related public health issues.[1]

Publications

The available academic record indicates five indexed documents associated with the researcher. These publications contribute to the scientific literature and provide measurable evidence of scholarly productivity. Publication activity remains an important indicator of academic engagement, allowing research findings to reach broader scientific and professional communities through peer-reviewed dissemination channels.[1]

Research Impact

Research impact can be evaluated through citation metrics, publication visibility, and influence on subsequent studies. With one hundred citations and an h-index of three, the documented scholarly profile demonstrates that published works have been referenced within the scientific community, indicating engagement with and recognition of the research outputs by other investigators.[1]

Award Suitability

The Best Researcher Award seeks to recognize individuals whose academic achievements demonstrate meaningful contributions to scientific advancement. Naima Nur’s publication record, citation performance, and involvement in microbiology-related research align with the objectives of the Global Diseases Research Awards, making her profile relevant for consideration within a research excellence and scholarly recognition framework.[1][2]

Conclusion

Naima Nur’s academic profile reflects documented participation in microbiology research through indexed publications, citation achievements, and scholarly engagement. Her contributions support scientific understanding in disease-related fields and align with the principles of academic excellence recognized by the Global Diseases Research Awards. The profile illustrates sustained commitment to research dissemination and knowledge development within the health sciences.[1]

References

1. Elsevier. (n.d.). Scopus author details: Naima Nur, Author ID 57297459000. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=57297459000

2. Global Diseases Research Awards. (n.d.). Best Researcher Award and Academic Recognition Programs.
https://globaldiseases.org/

3. Nur, N., Sharif, A. B., Khan, A., Islam, M. R., Soualhine, H., Nasreen, Z., Khan, A. H., Modak, P. K., Alam, M. F., Islam, S., Islam, S., Khan, N., & Sharma, M. K. (2026). Patterns of multidrug resistance and treatment outcomes among pulmonary tuberculosis patients in Bangladesh. Pathogens, 15(2), 208.
https://doi.org/10.3390/pathogens15020208

4. Hawlader, M. D. H., Rashid, M. U., Khan, M. A. S., et al. (2023). Quality of life of COVID-19 recovered patients: A 1-year follow-up study from Bangladesh. Infectious Diseases of Poverty, 12(1), 79.
https://doi.org/10.1186/s40249-023-01125-9

5. Nur, N., Sharif, A. B., & Mitra, D. K. (2023). Stress resilience in patients with drug-resistant tuberculosis. The International Journal of Tuberculosis and Lung Disease, 27(7), 551–556.
https://doi.org/10.5588/ijtld.22.0648

Ting Cheng | Epidemiology | Research Excellence Award

Published on by Global Diseases Research

Dr. Ting Cheng | Epidemiology | Research Excellence Award

Shanxi Medical University | China

Dr. Cheng Ting is a medical doctor and researcher affiliated with Shanxi Medical University, recognized for her contributions to autoimmune disease research, metabolic disorders, and chronic disease management. Her academic and clinical expertise spans rheumatology, endocrinology, osteoporosis, thyroid disorders, diabetes, and systemic autoimmune diseases. Dr. Cheng has actively contributed to translational medicine through clinical research projects and scientific publications focused on improving diagnosis, treatment, and patient outcomes. She has led provincial and hospital-level research projects and collaborated with national and international scientific communities. Her research achievements include SCI-indexed publications, academic book contributions, and patented medical innovations. Dr. Cheng has also gained international recognition through invited keynote lectures at major conferences, including EULAR and APLAR. Through her dedication to medical advancement, innovation, and patient-centered research, she continues to strengthen biomedical research and healthcare development both nationally and internationally.

Professional Profile

 

Education

Dr. Cheng Ting completed her medical education in China and earned her M.D. qualification with specialized training in internal medicine, autoimmune diseases, endocrinology, and chronic disease management. Her academic background provided extensive knowledge in clinical medicine, biomedical sciences, diagnostic methodologies, and evidence-based healthcare practices. During her advanced medical training, she developed strong expertise in rheumatology, osteoporosis research, metabolic diseases, and immune-related disorders. Her educational journey emphasized both theoretical medical sciences and practical clinical applications, enabling her to integrate patient care with scientific investigation. She further enhanced her academic profile through continuous participation in scientific conferences, professional workshops, and interdisciplinary medical collaborations. Her educational development also includes contributions to academic literature and participation in medical publishing activities. Through continuous learning and professional development, Dr. Cheng has established a strong academic foundation that supports her ongoing research in autoimmune diseases, metabolic health, chronic disease prevention, and translational clinical medicine.

Professional Experience

Dr. Cheng Ting has extensive professional experience in clinical medicine, biomedical research, and chronic disease management. She currently serves at Shanxi Medical University, where she combines patient care with advanced scientific research. Her clinical expertise includes the diagnosis and management of autoimmune diseases, osteoporosis, thyroid disorders, diabetes, and metabolic syndromes. Throughout her career, she has led two provincial and hospital-level research projects aimed at improving treatment strategies and healthcare outcomes. She has authored and co-authored several SCI-indexed research papers and contributed to multiple academic books related to medical sciences. Dr. Cheng also holds numerous national patents, reflecting her commitment to innovation and translational medicine. In addition to research and clinical responsibilities, she has been invited to present keynote speeches at internationally recognized conferences, including EULAR and APLAR. Her professional career demonstrates leadership, scientific excellence, and dedication to advancing global healthcare and medical research.

Research Interest 

Dr. Cheng Ting focuses her research on autoimmune diseases, metabolic disorders, rheumatology, endocrinology, and chronic disease prevention. Her studies investigate the mechanisms, diagnosis, and treatment strategies for conditions such as systemic sclerosis, osteoporosis, thyroid diseases, diabetes, and immune-mediated inflammatory disorders. She is particularly interested in translational medicine approaches that connect laboratory discoveries with clinical applications to improve patient outcomes. Her recent scientific contributions include research on viral infections and autoimmune diseases, as well as the clinical implications of nutritional interventions such as low-carbohydrate diets in autoimmune conditions. Dr. Cheng also emphasizes chronic disease management and preventive healthcare strategies aimed at reducing disease burden and improving long-term quality of life. Through multidisciplinary collaborations and evidence-based research methodologies, she continues to contribute to advancing biomedical science and precision medicine. Her research supports the development of innovative therapeutic approaches and improved healthcare systems for patients with autoimmune and metabolic disorders.

Awards and Honors

Dr. Cheng Ting has received several recognitions for her outstanding contributions to medical research, innovation, and healthcare advancement. One of her most notable achievements is receiving the Second Prize of the Shanxi Provincial Scientific and Technological Progress Award, which honors significant scientific contributions with practical healthcare impact. Her innovative work is further reflected in her ownership of 20 national patents related to medical technologies and healthcare solutions. Dr. Cheng has also earned professional recognition through invitations to deliver keynote speeches at major international and regional scientific conferences, including the European League Against Rheumatism (EULAR) and the Asia Pacific League of Associations for Rheumatology (APLAR). Her academic accomplishments include publishing multiple SCI-indexed papers and contributing to five academic books in the field of medicine and chronic disease management. These honors demonstrate her commitment to scientific innovation, translational medicine, clinical excellence, and international collaboration in biomedical and autoimmune disease research.

Conclusion

Dr. Cheng Ting  is a dedicated clinician, researcher, and innovator whose work significantly contributes to autoimmune disease research, metabolic medicine, and chronic disease management. With strong academic training, clinical expertise, research leadership, and international scientific engagement, she has established herself as an emerging contributor to biomedical and translational medicine. Her achievements include SCI-indexed publications, national patents, prestigious research awards, and keynote presentations at internationally recognized conferences. Dr. Cheng’s commitment to improving healthcare through scientific innovation and evidence-based medicine highlights her growing influence in global medical research. Her continued focus on interdisciplinary collaboration, translational medicine, and patient-centered healthcare positions her for further academic and professional excellence in the international biomedical research community.

Publications Top Noted

  • The application of low-carbohydrate diet in autoimmune diseases: Mechanisms, evidence, and prospects for clinical translation
    Authors: Ming-Fu Lu
    Citation: Autoimmunity Reviews | DOI: 10.1016/j.autrev.2026.104071
  •  Mendelian randomization unveils genetic causal relationships between viral infections and systemic sclerosis
    Authors: Ting Cheng
    Year: 2025
    Citation: Scientific Reports | DOI: Not provided

Viviana Malirat | Virology | Excellence in Research Award

Published on by Global Diseases Research

Dr. Viviana Malirat | Virology | Excellence in Research Award

Center for Human and Animal Virology | Argentina

Dr. Viviana Malirat is a virologist and veterinary researcher affiliated with Universidad Abierta Interamericana, Buenos Aires, Argentina, with recognized expertise in viral immunology, vaccine evaluation, and emerging infectious diseases. Her research focuses on foot-and-mouth disease virus, serological assay development, vaccine immunogenicity, and arboviral surveillance, including Oropouche virus. She has authored 36 Scopus-indexed publications, receiving over 870 citations and achieving an h-index of 16, reflecting sustained scientific impact. Dr. Malirat collaborates extensively with international research teams, contributing to improved disease control strategies, livestock health, and public health preparedness in endemic and emerging disease settings.

Citation Metrics (Scopus)

873
600
300
100
0

Citations

873

Documents

36

h-index

16

Citations

Documents

h-index

Top 5 Featured Publications

Gholamreza Mohammad | Infectious Diseases | Excellence in Field Epidemiology Award

Published on by Global Diseases Research

Prof. Dr. Gholamreza Mohammad | Infectious Diseases | Excellence in Field Epidemiology Award

Professor | ,Ferdowsi University of Mashhad | Iran

Prof. Dr. Gholamreza Mohammadi is a distinguished veterinary and infectious disease researcher at Ferdowsi University of Mashhad, Iran, recognized for his multidisciplinary contributions to zoonotic diseases, epidemiology, and animal health. With 43 scientific publications and more than 470 citations, he has established a strong academic footprint marked by rigorous field investigations, molecular analyses, and collaborative research across human and animal health sectors. His work spans major zoonotic pathogens—including Mycobacterium tuberculosis complex, Trypanosoma evansi, Cryptosporidium spp., and respiratory disorders in livestock—reflecting a sustained commitment to advancing One Health principles. Recent studies such as the longitudinal assessment of ultrasonographic lung consolidation in dairy calves, molecular insights into T. evansi in camels, and epidemiological evaluations of Cryptosporidium in lamb populations underscore his expertise in combining diagnostics, molecular epidemiology, and field surveillance. His collaborative record, with more than 90 co-authors, highlights active engagement in interdisciplinary networks that bridge veterinarians, microbiologists, epidemiologists, and public health specialists. Prof. Dr. Mohammadi’s research has contributed to improved disease detection, evidence-based livestock management, and enhanced understanding of cross-species disease transmission in northeastern Iran—an area of regional and global relevance due to its diverse ecological and agricultural systems. His open-access publications, including contributions to Scientific Reports, further demonstrate his commitment to knowledge dissemination and scientific transparency. Through sustained productivity, high-impact collaborations, and a focus on diseases that threaten both animal productivity and human well-being, Prof. Dr. Mohammadi continues to play a pivotal role in strengthening disease surveillance and shaping strategies for zoonotic disease prevention and control at the global level.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Razmi, G. R., Mohammadi, G. R., Garrosi, T., Farzaneh, N., Fallah, A. H., & Maleki, M. (2006). Seroepidemiology of Neospora caninum infection in dairy cattle herds in Mashhad area, Iran. Veterinary Parasitology, 135(2), 187–189. Cited by: 86

2. Tajik, J., Nadalian, M., Raoufi, A., Mohammadi, G. R., & Bahonar, A. (2009). Prevalence of subacute ruminal acidosis in some dairy herds of Khorasan Razavi province, northeast of Iran. Iranian Journal of Veterinary Research, 10(126), 28–32. Cited by: 76

3. Davari, E., Mohsenzadeh, M., Mohammadi, G. H., & Rezaeian-Doloei, R. (2015). Characterization of aflatoxigenic Aspergillus flavus and A. parasiticus strain isolates from animal feedstuffs in northeastern Iran. Iranian Journal of Veterinary Research, 16(2), 150. Cited by: 66

4. Mayameei, A., Mohammadi, G., Yavari, S., Afshari, E., & Omidi, A. (2010). Evaluation of relationship between Rotavirus and Coronavirus infections with calf diarrhea by capture ELISA. Comparative Clinical Pathology, 19(6), 553–557. Cited by: 60

5. Champour, M., Chinikar, S., Mohammadi, G., Razmi, G., Shah-Hosseini, N., & others. (2016). Molecular epidemiology of Crimean–Congo hemorrhagic fever virus detected from ticks of one-humped camels (Camelus dromedarius) population in northeastern Iran. Journal of Parasitic Diseases, 40(1), 110–115. Cited by: 56

Prof. Dr. Gholamreza Mohammadi is advancing global veterinary and zoonotic disease research through high-impact studies that improve animal health, safeguard food systems, and reduce cross-species transmission risks. His work integrates molecular epidemiology with real-world surveillance to strengthen public health preparedness and drive innovation in disease control strategies.

Kaiming Zhang | Infectious Disease | Best Scientist in Chronic Infectious Diseases

Published on by Global Diseases Research

Prof. Kaiming Zhang | Infectious Disease | Best Scientist in Chronic Infectious Diseases 

Professor | Shanxi Medical University | China

Prof. Kaiming Zhang is a researcher affiliated with Shanxi Medical University, Taiyuan, China, recognized for his expanding contributions to contemporary biomedical and clinical research. With 111 scientific publications, 896 citing documents, and over 1,300 citations, he has established a sustained scholarly presence reflected in an h-index of 22, demonstrating both productivity and the growing influence of his work. Dr. Zhang’s research portfolio spans multidisciplinary domains within medical science, contributing to the advancement of evidence-based understanding in areas relevant to public health, disease mechanisms, and clinical outcomes. His publications include peer-reviewed journal articles, emerging preprints, and collaborative studies with more than 120 co-authors, underscoring his strong integration within global scientific networks and cross-institutional partnerships. Through this collaborative engagement, Dr. Zhang actively supports the development of innovative methodologies, robust analytical frameworks, and data-driven insights that inform clinical practice and medical policy. His contributions are widely cited, reflecting their relevance across diverse research communities and their application in ongoing scientific progress. Dr. Zhang’s scholarly activities also demonstrate a commitment to scientific transparency and evolving research dissemination, with work represented across Scopus-indexed platforms and linked to ORCID for interoperable academic identity management. Although specific award information is not listed, the breadth and depth of his output underscore his dedication to advancing medical research and strengthening the global exchange of scientific knowledge. Overall, Dr. Kaiming Zhang exemplifies a modern clinician-researcher whose work enhances understanding of critical health challenges and contributes meaningfully to improved patient care, research innovation, and societal well-being.

Profiles: Scopus

Featured Publications

1. He, Y., Xing, J., Li, J., Zhang, K., & Li, X. (2025). S100A8 and S100A9-mediated keratinocyte affecting T lymphocyte immune imbalance through TLR4/NF-κB in psoriasis. Scientific Reports, 15(1). https://doi.org/10.1038/s41598-025-96874-y.

2. Liang, H., Wang, Y., Li, J., & Zhang, K. (2025). Crotonylation deficiency of S100A7 K49 promotes psoriatic keratinocyte proliferation through enhanced interaction with RAGE. Scientific Reports, 15(1), 14678. https://doi.org/10.1038/s41598-025-96874-y.

3. Liang, N., Cao, Y., Li, J., & Zhang, K. (2025). Normal dermal mesenchymal stem cells improve the functions of psoriatic keratinocytes by inducing autophagy. Acta Histochemica, 127(1), 152229. https://doi.org/10.1016/j.acthis.2025.152229.

4. Kuroda, K., Sapadin, A., Shoji, T., Fleischmajer, R., & Lebwohl, M. (2001). Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. Journal of Investigative Dermatology, 116(5), 713–720. https://doi.org/10.1046/j.1523-1747.2001.01316.x.
Cited by 124

Prof. Kaiming Zhang advances the molecular understanding of inflammatory and immune-mediated diseases, uncovering pathways that drive disease progression. His work provides essential foundations for developing targeted therapies and improving clinical outcomes worldwide.